Skip to Main Content

Combination Therapy in Oncology

White Paper|

By Matthew Haynes; Megan Thomas

This white paper's objectives are to:

  • Briefly identify key trends and drivers associated with the expanded use of combination therapies in oncology
  • Understand US payer expectations for management of combination therapies
  • Discuss future strategies for innovator development in the context of key trends

Combination Therapy in Oncology

Please submit the form below to view this resource.

Maximize value across the product and patient journeys. Find out how.